[Federal Register Volume 72, Number 166 (Tuesday, August 28, 2007)]
[Notices]
[Pages 49315-49316]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-16937]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 20, 2007, Cerilliant 
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed in schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
4-Methylaminorex (cis isomer) (1590).......  I
Gamma Hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
3,4,5-Trimethoxyamphetamine (7390).........  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2,5-Dimethoxyamphetamine (7396)............  I
2,5-Dimethoxy-4-ethylamphetamine (7399)....  I
3,4-Methylenedioxyamphetamine (7400).......  I
5-Methoxy-3,4-methylenedioxyamphetamine      I
 (7401).
N-Hydroxy-3,4-methylendioxyamphetamine       I
 (7402).
3,4-Methylendioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)...  I
4-Methoxyamphetamine (7411)................  I
Alpha-methyltryptamine (7432)..............  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
Acetyldihydrocodeine (9051)................  I
Benzylmorphine (9052)......................  I
Codeine-N-oxide (9053).....................  I
Dihydromorphine (9145).....................  I
Heroin (9200)..............................  I
Hydromorphinol (9301)......................  I
Methyldihydromorphine (9304)...............  I
Morphine-N-oxide (9307)....................  I
Normorphine (9313).........................  I
Pholcodine (9314)..........................  I
Acetylmethadol (9601)......................  I
Allylprodine (9602)........................  I
Alphacetylmethadol except levo-              I
 alphacetylmethadol (9603).
Alphameprodine (9604)......................  I
Alphamethadol (9605).......................  I
Betacetylmethadol (9607)...................  I
Betameprodine (9608).......................  I
Betamethadol (9609)........................  I
Betaprodine (9611).........................  I
Hydroxypethidine (9627)....................  I
Noracymethadol (9633)......................  I
Norlevorphanol (9634)......................  I
Normethadone (9635)........................  I
Trimeperidine (9646).......................  I
Phenomorphan (9647)........................  I
Para-Fluorofentanyl (9812).................  I
3-Methylfentanyl (9813)....................  I
Alpha-Methylfentanyl (9814)................  I
Acetyl-alpha-methylfentanyl (9815).........  I
Beta-hydroxyfentanyl (9830)................  I
Beta-hydroxy-3-methylfentanyl (9831).......  I
Alpha-Methylthiofentanyl (9832)............  I
3-Methylthiofentanyl (9833)................  I
Thiofentanyl (9835)........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phenmetrazine (1631).......................  II
Methylphenidate (1724).....................  II
Ambobarbital (2125)........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Glutethimide (2550)........................  II
Nabilone (7379)............................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II

[[Page 49316]]

 
1-Piperidinocyclohexane carbonitrile (8603)  II
Alphaprodine (9010)........................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Noroxymorphone (9668)......................  II
Racemethorphan (9732)......................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards which will be 
distributed to their customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such comments or objections being sent via regular mail should 
be addressed, in quintuplicate, to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
Washington, DC 20537; or any being sent via express mail should be sent 
to Drug Enforcement Administration, Office of Diversion Control, 
Federal Register Representative (ODL), 2401 Jefferson-Davis Highway, 
Alexandria, Virginia 22301; and must be filed no later than October 29, 
2007.

    Dated: August 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-16937 Filed 8-27-07; 8:45 am]
BILLING CODE 4410-09-P